vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and FIRST CAPITAL INC (FCAP). Click either name above to swap in a different company.

Fortress Biotech, Inc. is the larger business by last-quarter revenue ($16.1M vs $13.5M, roughly 1.2× FIRST CAPITAL INC). FIRST CAPITAL INC runs the higher net margin — 36.2% vs -24.5%, a 60.7% gap on every dollar of revenue. On growth, FIRST CAPITAL INC posted the faster year-over-year revenue change (19.0% vs 6.3%). Over the past eight quarters, FIRST CAPITAL INC's revenue compounded faster (13.4% CAGR vs 11.0%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

Capital First Ltd, formerly known as Future Capital Holdings, was an Indian non-bank financial institution which provided debt financing. In December 2018, it was merged into IDFC Bank to form IDFC First Bank. The company was listed on the NSE and BSE prior to the merger.

FBIO vs FCAP — Head-to-Head

Bigger by revenue
FBIO
FBIO
1.2× larger
FBIO
$16.1M
$13.5M
FCAP
Growing faster (revenue YoY)
FCAP
FCAP
+12.7% gap
FCAP
19.0%
6.3%
FBIO
Higher net margin
FCAP
FCAP
60.7% more per $
FCAP
36.2%
-24.5%
FBIO
Faster 2-yr revenue CAGR
FCAP
FCAP
Annualised
FCAP
13.4%
11.0%
FBIO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FBIO
FBIO
FCAP
FCAP
Revenue
$16.1M
$13.5M
Net Profit
$-3.9M
$4.9M
Gross Margin
66.1%
Operating Margin
-28.8%
Net Margin
-24.5%
36.2%
Revenue YoY
6.3%
19.0%
Net Profit YoY
41.8%
49.6%
EPS (diluted)
$-0.15
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
FCAP
FCAP
Q4 25
$16.1M
$13.5M
Q3 25
$17.6M
$13.3M
Q2 25
$16.4M
$12.4M
Q1 25
$13.1M
$11.4M
Q4 24
$15.1M
$11.3M
Q3 24
$14.6M
$10.9M
Q2 24
$14.9M
$10.7M
Q1 24
$13.0M
$10.5M
Net Profit
FBIO
FBIO
FCAP
FCAP
Q4 25
$-3.9M
$4.9M
Q3 25
$5.8M
$4.5M
Q2 25
$15.5M
$3.8M
Q1 25
$-10.6M
$3.2M
Q4 24
$-6.8M
$3.3M
Q3 24
$-12.9M
$2.9M
Q2 24
$-10.9M
$2.8M
Q1 24
$-15.4M
$3.0M
Gross Margin
FBIO
FBIO
FCAP
FCAP
Q4 25
66.1%
Q3 25
67.4%
Q2 25
69.9%
Q1 25
63.5%
Q4 24
69.1%
Q3 24
69.4%
Q2 24
61.6%
Q1 24
53.9%
Operating Margin
FBIO
FBIO
FCAP
FCAP
Q4 25
-28.8%
Q3 25
-38.6%
41.8%
Q2 25
-222.2%
37.2%
Q1 25
-169.9%
34.2%
Q4 24
-158.3%
34.8%
Q3 24
-151.0%
31.5%
Q2 24
-186.5%
31.1%
Q1 24
-280.6%
33.0%
Net Margin
FBIO
FBIO
FCAP
FCAP
Q4 25
-24.5%
36.2%
Q3 25
33.2%
33.8%
Q2 25
94.4%
30.4%
Q1 25
-80.6%
28.3%
Q4 24
-44.7%
28.8%
Q3 24
-88.0%
26.5%
Q2 24
-73.5%
26.5%
Q1 24
-118.3%
28.1%
EPS (diluted)
FBIO
FBIO
FCAP
FCAP
Q4 25
$-0.15
$1.45
Q3 25
$0.11
$1.34
Q2 25
$0.45
$1.13
Q1 25
$-0.48
$0.97
Q4 24
$-0.16
$0.97
Q3 24
$-0.76
$0.87
Q2 24
$-0.73
$0.85
Q1 24
$-1.04
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
FCAP
FCAP
Cash + ST InvestmentsLiquidity on hand
$79.4M
Total DebtLower is stronger
$52.4M
Stockholders' EquityBook value
$49.9M
$137.8M
Total Assets
$185.5M
$1.3B
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
FCAP
FCAP
Q4 25
$79.4M
Q3 25
$86.2M
Q2 25
$74.4M
Q1 25
$91.3M
Q4 24
$57.3M
Q3 24
$58.9M
Q2 24
$76.2M
Q1 24
$83.8M
Total Debt
FBIO
FBIO
FCAP
FCAP
Q4 25
$52.4M
Q3 25
$47.8M
Q2 25
$50.0M
Q1 25
$56.4M
Q4 24
$58.0M
Q3 24
$52.5M
Q2 24
$67.0M
Q1 24
$61.4M
Stockholders' Equity
FBIO
FBIO
FCAP
FCAP
Q4 25
$49.9M
$137.8M
Q3 25
$55.9M
$132.4M
Q2 25
$43.9M
$123.2M
Q1 25
$22.3M
$120.1M
Q4 24
$22.7M
$114.6M
Q3 24
$21.2M
$116.8M
Q2 24
$17.9M
$107.8M
Q1 24
$23.0M
$105.7M
Total Assets
FBIO
FBIO
FCAP
FCAP
Q4 25
$185.5M
$1.3B
Q3 25
$181.4M
$1.2B
Q2 25
$159.9M
$1.2B
Q1 25
$178.1M
$1.2B
Q4 24
$144.2M
$1.2B
Q3 24
$127.1M
$1.2B
Q2 24
$145.7M
$1.2B
Q1 24
$164.6M
$1.2B
Debt / Equity
FBIO
FBIO
FCAP
FCAP
Q4 25
1.05×
Q3 25
0.86×
Q2 25
1.14×
Q1 25
2.53×
Q4 24
2.55×
Q3 24
2.48×
Q2 24
3.75×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
FCAP
FCAP
Operating Cash FlowLast quarter
$-12.5M
$21.3M
Free Cash FlowOCF − Capex
$19.9M
FCF MarginFCF / Revenue
147.7%
Capex IntensityCapex / Revenue
10.0%
Cash ConversionOCF / Net Profit
4.36×
TTM Free Cash FlowTrailing 4 quarters
$35.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
FCAP
FCAP
Q4 25
$-12.5M
$21.3M
Q3 25
$-6.1M
$7.9M
Q2 25
$-27.6M
$3.7M
Q1 25
$-19.6M
$4.4M
Q4 24
$-12.9M
$22.3M
Q3 24
$-20.1M
$7.6M
Q2 24
$-21.8M
$3.5M
Q1 24
$-25.4M
$7.2M
Free Cash Flow
FBIO
FBIO
FCAP
FCAP
Q4 25
$19.9M
Q3 25
$7.8M
Q2 25
$3.5M
Q1 25
$4.2M
Q4 24
$21.6M
Q3 24
$7.5M
Q2 24
$3.3M
Q1 24
$7.1M
FCF Margin
FBIO
FBIO
FCAP
FCAP
Q4 25
147.7%
Q3 25
58.6%
Q2 25
27.8%
Q1 25
36.5%
Q4 24
190.7%
Q3 24
68.6%
Q2 24
31.2%
Q1 24
67.2%
Capex Intensity
FBIO
FBIO
FCAP
FCAP
Q4 25
10.0%
Q3 25
1.2%
Q2 25
2.2%
Q1 25
1.9%
Q4 24
6.3%
Q3 24
0.0%
0.8%
Q2 24
1.4%
Q1 24
1.5%
Cash Conversion
FBIO
FBIO
FCAP
FCAP
Q4 25
4.36×
Q3 25
-1.04×
1.77×
Q2 25
-1.78×
0.99×
Q1 25
1.36×
Q4 24
6.84×
Q3 24
2.62×
Q2 24
1.23×
Q1 24
2.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons